🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Meeting of the ERN liver vascular group cochaired by Aurelie and Valerie. Nice work 👏🏻👏🏻👏🏻 ERN RARE LIVER LiverUnit.Clinic.BCN Valdig Group EASL Education IDIBAPS Hospital Clínic

Terlipressin received FDA approval for HRS-AKI. mnk.com/about/news-and… Avoid use in patients with ACLF grade 3 and do not initiate if patient hypoxemic (e.g. SpO2<90%). Patients with SCr>5 unlikely to benefit.

💥Hey, our 🔥brand new video 📹of the @ERNRARELIVER Members' Meeting is out! We are happy😄to share all those special moments, talks and information and look forward to our annual meeting next year on 1st and 2nd September 2023. See Video: youtu.be/wUzhvZPbmi0 #livertwitter

Juan G Abraldes Journal of Hepatology Oleksandr Petrenko | opetrenko.bsky.social CeMM Papers CeMM MedUni Wien Mattias Mandorfer Rautou Pierre-Emmanuel JC Garcia Pagan Virginia Jonel Trebicka @BavenoVII jaumebosch Annalisa Berzigotti Guadalupe GarciaTsao Important credit goes to Rautou Pierre-Emmanuel JC Garcia Pagan Virginia Filippo_Schepis who all together with us Mattias Mandorfer provided #HVPG datasets of >1200 cACLD patients. #livertwitter Journal of Hepatology #cirrhosis

The Second AISF - Associazione Italiana Studio Fegato training day in Rome. It was wonderful to meet the future Italian leaders in Hepatology Giuseppe Cabibbo Vincenza Calvaruso Sara Montagnese quirino lai #livertwitter

📢 All you need to know about the assessment of glomerular filtration rate in patients with #cirrhosis in a single new review that you can not miss: 🔓 ow.ly/lRak50KYGoQ #livertwitter #openaccess #AKI #liverreviews

About last night....the end of a fantastic journey! ❤ @PhDCerimony UNIMORE PhD School in Clinical and Experimental Medicine

Key messages from my talk today in the AASLD meeting: - Alc Hepatitis is influenced by epigenetic rather than genetic factors. - Biomarkers of SIRS (IL-6) and infections (procalcitonin) may guide therapy. #livertwitter

Ramon Bataller AASLD I strongly aree with you Ramon. In particular on the use of PCT to make a quick decision to treat infenctions

It's #LiverCancerAwarenessMonth! ✍️and it's the right time to sign our Open Letter to the EU Institutions with 10 asks to improve liver cancer care and prevention. Thomas Berg Aleksander Krag josé willemse Milan 👉easl.eu/10asks/

"Simple mindset shifts: - I'm not hurt, I'm healing. - I'm not losing, I'm learning. - I was not rejected, I was redirected. Negative things happen. Negative mindsets make them harder." – James Clear

Our work on #markers of #PortalHypertension in #HIV just published in Liver International ! doi.org/10.1111/liv.15… #OpenAccess #livertwitter IDIGH The CTN+ | Le Réseau+ CASL Bertrand LEBOUCHE McGill_DOM Jovana Milić Sanjay Bhagani Anaïs Corma-Gómez Filippo_Schepis Annalisa Berzigotti Sahar Saeed

Day2 French 🇫🇷 #TIPS Guideline Meeting 🩸 pre-emptive / early TIPS for varicesl bleeding 💧TIPS for recurrent / refractory ascites 🧠 Prophylaxis of Encephalopathy after TIPS 💪 Sarcopenia improves after TIPS

Thomas Reiberger Virginia JC Garcia Pagan bogdan procopet It was a great meeting thanks to AFEF, Cristophe Bureau and Hélène Larrue. Very interesting discussion with good friends.

2️⃣ Session of the Workshop Vascular Liver Diseases in Padua, Italy 🇮🇹 introducing and discussing research strategies in VLD. 🎯How to involve patients in research (Sophie Hullin) 💡New techniques +data (Valerie Paradis) ➡️European Grants (Virginia Hernandez-Gea) #ERN_RARE_LIVER

Wonderful! looking very much forward to welcoming you to EASLnews Clinical School of Hepatology #EASLedu #Alcohol related Liver Disease- #SLD, #MetALD, #ALD - name it we got it ( if ALD is part😀 team FLASH - Liver Research 👇 ready to host our guests ❤️